Boardroom Alpha
Boardroom Alpha
XOS · Additional Proxy Materials (DEFA14A) · Filed May 13, 2026

Xos Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
May 13, 2026
Ticker
XOS
Accession
0001819493-26-000035
Boardroom Alpha · Filing insights

Xos discloses a Third A&R Convertible Note with a reduced conversion price and mandatory conversion trigger. Proposal 6 requires stockholder approval, and Aljomaih could own approximately 28%.

About Xos Inc
Market cap
$50M
1Y TSR
−13.7%
3Y TSR
−36.8%
Board grade
C-
Sector
Consumer Cyclical
CEO
Dakota Semler
Last annual meeting: Jun 23, 2026 · View full Xos Inc profile →
xos-20260513

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.__)
____________________________
Filed by the Registrantx
Filed by a Party other than the Registranto
Check the appropriate box:
oPreliminary Proxy Statement
oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
oDefinitive Proxy Statement
xDefinitive Additional Materials
oSoliciting Material Pursuant to § 240.14a-12
Xos, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
xNo fee required.
oFee paid previously with preliminary materials
oFee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11




Xos.jpg
XOS, INC.
3550 Tyburn Street
Los Angeles, CA 90065

This proxy statement supplement, dated May 13, 2026 (this “Supplement”) supplements the definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) filed by Xos, Inc. (the “Company,” “we,” “us” or “our”) with the Securities and Exchange Commission (the “SEC”) on May 4, 2026 in connection with the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”), which will be held virtually via webcast at www.virtualshareholdermeeting.com/XOS2026 on Tuesday, June 23, 2026, at 11:00 a.m. Pacific Daylight Savings Time. This Supplement should be read in conjunction with the Definitive Proxy Statement. To the extent the information set forth herein differs from or updates information contained in the Definitive Proxy Statement, the information set forth herein shall supersede or supplement the information in the Definitive Proxy Statement. All other information in the Definitive Proxy Statement remains unchanged.
Third Amended and Restated Convertible Promissory Note
As disclosed in the Definitive Proxy Statement, stockholders are being asked to approve, among other things, the potential issuance of 20% or more of the Company’s issued and outstanding common stock at prices that may be less than the Nasdaq Minimum Price to the holder or holders of the convertible promissory note issued to Aljomaiih Automotive Co. (“Aljomaih”), and the approval of any change of control that may be deemed to occur in connection with such issuance (“Proposal 6”).
On May 8, 2026, the Company and Aljomaih entered into a Third Amended and Restated Convertible Promissory Note (the “Third A&R Note”). The Third A&R Note amended the convertible promissory note issued by the Company to Aljomaih on August 11, 2022, in an original principal amount of $20 million (as subsequently amended, the “Convertible Note”) to reduce the conversion price from $71.451 per share (as adjusted for the 1-for-30 reverse stock split effected on December 6, 2023) of the Company's common stock, par value $0.0001 per share (“Common Stock”), to $12.00 per share of Common Stock (subject to customary proportional adjustment). The Third A&R Note also adds a mandatory conversion feature to the Convertible Note pursuant to which the Company may compel the conversion of the Convertible Note if the Daily VWAP (as defined in the Convertible Note) of the Common Stock exceeds $16.00 per share (subject to customary proportional adjustment) for at least twenty out of thirty consecutive trading days. The Convertible Note is otherwise unchanged in any material respect.
The Third A&R Note constitutes a “Covered Potential Amendment” to the Convertible Note, as described in Proposal 6 in the Definitive Proxy Statement. Accordingly, approval by our stockholders of Proposal 6 will constitute approval of the issuance of the shares to be issued pursuant to the Third A&R Note pursuant to Nasdaq Listing Rule 5635(b) and Nasdaq Listing Rule 5635(d), as described in the Definitive Proxy Statement. As a result of the Third A&R Note, and the scheduled May 11, 2026 repayment of $1.5 million principal amount thereof, the $15.5 million outstanding principal amount of the Note is now convertible into 1,291,666 shares of Common Stock.
Based solely on information obtained from a Schedule 13D/A filed with the SEC on May 8, 2026 on behalf of Aljomaih and transactions directly between us and Aljomaih, including the Third A&R Note and the May 11, 2026 scheduled principal repayment, as of May 11, 2026, Aljomaih may be deemed to beneficially own 3,738,303 shares of Common Stock, representing approximately 28.0% of the Company's outstanding Common Stock. Such beneficial ownership consists of (i) 2,446,637 shares held directly by Aljomaih and (ii) 1,291,666



shares that Aljomaih has the right to acquire upon conversion of the $15.5 million outstanding principal amount of the Note. This does not include shares issuable by the Company in payment of interest accrued on the Convertible Note.
The description of the Third A&R Note above is a summary only and is qualified in its entirety by reference to the full text of the Third A&R Note, which is filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 13, 2026, which is incorporated herein by reference.
Voting Matters
Please note that any proxy card we delivered to you in connection with the Annual Meeting has not changed and may still be used to vote your shares in connection with the Annual Meeting. If you have already submitted your vote, you do not need to take any further action. All stockholders of record as of April 24, 2026 should have received a Notice of Internet Availability of Proxy Materials (the “Notice”), which provides instructions on how to access proxy materials and vote online, or a full set of paper proxy materials, if requested. Proxy materials are available at www.proxyvote.com and may also be accessed through our website at www.xostrucks.com under the “SEC Filings” section of the “Investors” tab. Stockholders may vote online at the Annual Meeting, vote by proxy over the telephone, vote by proxy through the internet or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time.
There are six items that stockholders are asked to vote on at this year’s Annual Meeting, including the election of three Class II directors, ratification of the appointment of Grant Thornton LLP as our independent auditors, an amendment to our equity incentive plan, non-binding advisory resolutions concerning executive compensation and the frequency of the “Say on Pay” vote, as well as Proposal 6. The Board recommends that stockholders vote “FOR” each Class II director nominee, “FOR” each proposal and for a frequency of “ONE YEAR” on proposal five. If voting by proxy, please do so as soon as possible to avoid additional Company expenses or meeting delays.

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Xos Inc (XOS)

Reference

Frequently asked questions

When did Xos Inc file this DEFA14A?
Xos Inc (XOS) filed this Additional Proxy Materials (DEFA14A) with the SEC on May 13, 2026. The accession number assigned by EDGAR is 0001819493-26-000035.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Xos discloses a Third A&R Convertible Note with a reduced conversion price and mandatory conversion trigger. Proposal 6 requires stockholder approval, and Aljomaih could own approximately 28%. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Xos Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Xos Inc has filed under CIK 1819493, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer